Status:
COMPLETED
Epidemiology and Outcome of Anaphylactic Shocks Admitted to Intensive Care Unit
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Anaphylaxis
Eligibility:
All Genders
18+ years
Brief Summary
Anaphylaxis is a severe life-threatening reaction following exposure to an antigen. Its incidence is progressively increasing in the general population over years, accompanied with an increased number...
Eligibility Criteria
Inclusion
- Being \> 18 years old
- suffered an anaphylactic reaction, regardless of the location or causative allergen
- transferred alive in an ICU
Exclusion
- dead within less than one hour after admission
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
339 Patients enrolled
Trial Details
Trial ID
NCT04290507
Start Date
January 1 2017
End Date
December 31 2019
Last Update
March 11 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Nancy
Nancy, France, 54511
2
University Hospital of Strasbourg
Strasbourg, France